UK markets closed

Novo Nordisk A/S (NONOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
109.50+2.80 (+2.63%)
At close: 03:48PM EDT
Sign in to post a message.
  • L
    Larry
    Wonderful company but earnings are growing at 12% whilst the P/E is up at 35.
    With a PEG ratio of 2.28, couldn't you sell everything, sit on your hands and buy this back well below $100?

    As I say - wonderful company but?

    Any arguments as to why this will grow faster than 12%?
    Or is it blind belief in a weight loss drug?
  • D
    DC
    Lilly's drug will NEVER be in pill form. NVOs will and sooner than u think. Pills win over injections every time
  • L
    Larry
    This is going to really struggle from here on a P/E of 35. It's up 33% this past 13 months and the valuation is really stretched.
  • L
    Larry
    Looks like Eli Lilly has stolen a march on Novo with its obesity drug. Apparently it mimics two hormones compared to just one for Novo and gives greater weight loss by further kerbing the appetite.
  • D
    DC
    NVO reps will be outside of Walmarts handing out free samples of Wegovy. Lilly reps will be giving their samples with roll of TP
  • S
    Sudheendra
    nvo is a BUY...will do great...i have been accumulating every dip...long term stock
  • f
    fleckola
    Buying back shares. Waiting to be able to produce enough Wegovy in house and finish stock buyback before releasing the tremendous weight loss and overall health benefits of Wegovy. When results are released stock will soar.
  • B
    Brian
    I'm out. I should have sold everything at 120 instead of buying more. Cost me over 10k
  • g
    goodwine
    Wow! I just found a site that gives the top NOVO-B.CO to trade every single day for free! (http://traderspot.club)
  • S
    Sudheendra
    is ILLY obesity drug better than NVO wegovy???
  • S
    Sudheendra
    why is NVO down so much...inspite of strong buy rating???
  • S
    Sudheendra
    NVO is an evergreen stock for long term …..did great again
  • B
    Brian
    52 week high when market retreats and goes into defensive healthcare
  • D
    DC
    Lilly's new drug has high rate of vomiting and diarrhea hence weight loss.
  • D
    DC
    Lilly's new Type 2 drug good for 1 thing. CONSTIPATION
  • B
    Brian
    Watch when earnings come out. Wegovy will be the number 1 weight loss drug in the world and most insurance well pay for it. With a monopoly on the gold standard for doctor prescribed weight loss, NVO will shoot right back up into the 120s to 130s
  • D
    DC
    Lily's new drug shows about same wt loss as NVOs. BUT we will have ours in PILL form shortly. They never will.
  • B
    Brian
    Also, the U.S. Senate is likely going to pass insulin price caps. Unless Republicans block it. If the GOP blocks the insulin cap, then at least that will benefit NVO
  • B
    Brian
    NVO is a defensive play in this market. it's strange bcz on a down day, it should be up. What keeps me from going all in on it is the U.S. legislation of insulin. GOP is opposed to it, but GOP probably has more fat diabetic voters than Dems do. GOP has a history of ignoring the pocketbook issues of individuals and snookering them into voting guns and religion, so insulin regulation and legislation is probably not going to happen.